News
The Move GBS Forward campaign highlights a promising new approach to treatment of the disease. Annexon Biosciences CEO Doug ...
While most recover, early treatment is critical. Preventive measures focus on infection control and maintaining overall health. Guillain-Barré Syndrome (GBS) is a rare but serious neurological ...
Kolhapur health authorities said they will now investigate the Shahu Mill neighbourhood to determine what caused GBS in the 65-year-old resident. "We will be testing water samples too. More ...
Annexon Biosciences launched a new campaign to raise awareness with HCPs about the risk of Guillain-Barre Syndrome (GBS) and new treatment options. 1 The Move GBS Forward campaign is focused on ...
On the strength of phase 2 data, the FDA has awarded coveted breakthrough status to Pfizer's vaccine against Group B Streptococcus (GBS), given to expectant mothers to prevent invasive infections ...
The last major breakthrough in GBS treatment was nearly four decades ago. The most widely used treatments -- intravenous immunoglobulin, or IVIG, and plasma exchange -- can offer relief but are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results